Launch of ControlRad Trace Radiation Reduction Technology for Mobile C-Arms

By Julie A. Vetalice

ControlRad gained FDA 510(k) clearance and commenced commercial launch of ControlRad Trace, technology that integrates with existing mobile C-arms to reduce radiation in any fluoroscopic imaging procedure.

ControlRad Trace features a proprietary semi-transparent filter, tablet and image processing technology, and can be retrofitted on existing C-arms, thus reducing barriers to adoption. The device can reduce unnecessary radiation up to 89%, without compromising image quality in the region of interest and overall workflow. This is critical for medical personnel and patients, considering that an interventional fluoroscopy procedure is roughly equivalent to the adult effective dose of between 250 and 3,500 chest x-rays.

“With over 17 million fluoroscopic procedures in the U.S. every year, the ControlRad Trace is the only system available that can impact all of them,” says Chris Fair, ControlRad Executive Vice President and President, Mobile C-arm division. “Regardless if it is a pain management treatment, an orthopedic trauma case or even a minimally invasive spine procedure, our technology will reduce radiation exposure and protect those who are saving the lives of others.”

Source: ControlRad

Tags: 510(k) Clearance, Regulatory